In Brief
Editing macrophage polarization is an emerging concept for the treatment of inflammatory diseases. Van den Bossche et al. show that inflammatory M1 macrophage activation dampens mitochondrial function, thereby preventing the repolarization to an antiinflammatory M2 phenotype. Inhibiting nitric oxide production improves mitochondrial function and reprogramming to M2 macrophages.
INTRODUCTION
In addition to their function in host defense, macrophages secure tissue homeostasis and dampen inflammatory responses (Okabe and Medzhitov, 2016; Wynn et al., 2013) . To carry out these seemingly contrasting functions, macrophages show high plasticity and adopt a spectrum of polarization states, among which M1 and M2 cells are the extremes (Xue et al., 2014) . M1 macrophages are induced by the Th1 cytokine interferon-g (IFNg) in combination with Toll-like receptor (TLR) ligands, such as lipopolysaccharide (LPS), and they are, therefore, also termed M(LPS + IFNg) (Murray et al., 2014) . These cells secrete pro-inflammatory cytokines; produce reactive oxygen and nitrogen species to ensure efficient microbial killing; and show enhanced MHC-I/II, CD80, and CD86 expression. However, continuous M1 activation may cause collateral tissue damage and chronic inflammation (Sica and Mantovani, 2012) .
Macrophages are also activated by diverse non-inflammatory factors. Although non-M1 macrophages are often grouped as M2, the Th2 cytokines IL-4 and IL-13 are the only inducers of the so-called alternatively activated macrophages (AAMs; M and M2a) (Gordon and Martinez, 2010; Murray et al., 2014; Sica and Mantovani, 2012) . Functionally, M2 macrophages dampen Th1/M1-driven inflammation, promote tissue repair, and mediate Th2-driven pathologies, such as asthma and helminth infections. At the molecular level, M2 macrophages are characterized by a range of specific marker genes, surface markers, and enzymes (Gordon and Martinez, 2010; Martinez et al., 2013; Van den Bossche et al., 2009 . For clarity, we will hereafter refer to IL-4-induced macrophages as M2 and to LPS + IFNg-elicited macrophages as M1 cells.
Editing macrophage (re)polarization is emerging as a new therapeutic approach (Hagemann et al., 2008; Sica and Mantovani, 2012; Wynn et al., 2013) . For example, reprogramming tumorpromoting M2-like tumor-associated macrophages into anti-tumor M1-like cells is being tested as a cancer treatment (Colombo et al., 1992; Hagemann et al., 2008; Sica and Mantovani, 2012) . Conversely, the treatment of chronic inflammatory diseases, such as atherosclerosis and rheumatoid arthritis, will benefit from the repolarization of inflammatory M1 into anti-inflammatory M2 macrophages. While the apparent switch from M1 to M2 characterizes the course of repair and anti-microbial responses (Das et al., 2015; Rigamonti et al., 2014; Van den Bossche et al., 2009; Wynn et al., 2013) , in vivo evidence of M1/M2 repolarization is lacking. Indeed, it is a continuing debate whether the sequential presence of M1 and M2 macrophages results from actual repolarization as a response to the changing microenvironment or from the recruitment of new monocytes to a repair-promoting local milieu (Das et al., 2015; Italiani and Boraschi, 2014; Rigamonti et al., 2014) .
Metabolic cascades are increasingly recognized as characteristics and controllers of macrophage activation (Galvá n-Peñ a and O 'Neill, 2014; Jha et al., 2015; Ouimet et al., 2015) . M1 cells use glycolysis for rapid killing, whereas M2 macrophages rely on mitochondrial oxidative phosphorylation (OXPHOS) for sustained energy production (Cramer et al., 2003; Huang et al., 2014; Tan et al., 2015; Tannahill et al., 2013; Vats et al., 2006) . These metabolic cascades do not only reflect macrophage energy production but also directly dictate the phenotype. As such, glycolysis drives inflammatory macrophage responses (Cramer et al., 2003; Tannahill et al., 2013) , and OXPHOS supports M2 activation (Tan et al., 2015; Vats et al., 2006) .
Here, we show that M1 activation inhibits mitochondrial function, thereby impairing future IL-4-responses. Inhibiting inducible nitric oxide synthase (iNOS) in mouse macrophages dampened the LPS + IFNg-induced decline in mitochondrial respiration and improved the metabolic and phenotypic M1/M2 repolarization.
RESULTS

Mouse M1 Macrophages Fail to Repolarize to M2 upon IL-4 Restimulation In Vitro
Given that the treatment of chronic inflammatory diseases could profit from the repolarization of inflammatory into anti-inflammatory macrophages, we assessed the repolarization capacity of M1 cells. Hereto, we first compared the IL-4-induced response of mouse bone marrow-derived macrophages (BMMs) that had been pre-treated with LPS + IFNg ( Figure 1A , cyan checkered) with the response of normal M2 cells (cyan). Inflammatory M1 macrophages did not exhibit efficient upregulation of the M2-specific marker genes Cdh1 (E-cad), Chi3l3, Mrc1, and (D) Arginase activity in BMM lysates was measured and shown as units (U) enzymatic activity. Values represent mean ± SEM of three mice (*p < 0.05, **p < 0.01, and ***p < 0.001; ns, not significant).
Retnla, when the cells were washed and stimulated 30 min afterward with IL-4 for 24 hr ( Figure 1B) . Also, when the M1 cells were allowed to recover for 24 hr between the first inflammatory response and the subsequent M2 repolarization, IL-4 failed to elicit an efficient M2 gene signature ( Figure S1 ). In accordance with the gene expression data, the M2 surface markers CD71, CD206, and CD301 were not induced by IL-4 following LPS + IFNg stimulation ( Figure 1C ). Despite the fact that Arg1 gene expression was plastic and was still inducible by IL-4 after LPS + IFNg stimulation ( Figure 1B ), M1/M2 macrophages showed significantly less IL-4-induced arginase function compared to M2 cells ( Figure 1D ). Likewise, LPS + IFNg pretreatment impaired the induction of an IL-10-elicited M2-like phenotype ( Figure S2 ).
Next, we studied the capacity of M2 macrophages to mount an inflammatory response by comparing the LPS + IFNginduced response of M2/M1 ( Figure S3A , red checkered) with the response of normal M1 cells (red). We found that, independent of the first stimulus, LPS + IFNg efficiently induced the M1-associated genes Il12b, Il1b, Il6, Nos2, and Tnf in both M2/M1 and M1 cells ( Figure S3B ). The repolarization capacity of IL-4-induced macrophages was further reflected at the protein level, as M2/M1 and M1 macrophages displayed identical CD80 and CD86 expression ( Figure S3C ) Functionally, M2/M1 and M1 macrophages showed similar inflammatory cytokine secretion and iNOS-mediated nitric oxide (NO) production ( Figures S3D and S3E) . Thus, while mouse M2 macrophages readily repolarized to a pro-inflammatory state upon LPS + IFNg restimulation, M1 activation prevented subsequent M2 polarization in vitro.
Human Inflammatory Macrophages Do Not Repolarize to M2
To test the relevance of these findings for humans, we studied the M1/M2 repolarization of peripheral blood monocytederived human macrophages (MoDMs) (Figure 2A ). Confirming our studies with mouse macrophages, human M1 macrophages showed strongly impaired IL-4-induced expression of the M2 marker genes CCL22, CCL24, CD200R, CD206, and FCER2 (CD23) ( Figure 2B ). In accordance, the M2 surface markers CD23, CD200R, and CD206 were not induced by IL-4 after prior LPS + IFNg stimulation ( Figure 2C ). Thus, both mouse and human macrophages completely failed to accept an IL-4-induced state after a preceding inflammatory stimulus. Conversely, human IL-4-induced M2 cells reversed to an inflammatory state upon LPS + IFNg treatment, as evidenced by the high expression of M1 marker genes and surface markers and by the enhanced secretion of inflammatory cytokines (Figures S4A-S4D ). Thus, while M2/M1 repolarization efficiently occurred in both mouse and human macrophages, the opposite M1/M2 conversion was impossible.
Inflammatory Macrophages Fail to Repolarize to M2 In Vivo Next, we studied whether the M1/M2 repolarization defect that we observed in vitro also has relevance in vivo. To test this, untreated (N) or LPS + IFNg-treated (M1) BMMs from CD45.1 + donor mice were adoptively transferred intraperitoneally to CD45.2 + acceptor mice, which next received an intraperitoneal challenge with IL-4c to induce M2 polarization ( Figure 3A ). LPS + IFNg-treated macrophages showed strongly enhanced inflammatory cytokine secretion and NO production ( Figure 3B ). Confirming our mouse and human in vitro observations, these M1-primed macrophages failed to upregulate CD71, CD206, and CD301 M2 surface marker expression upon in vivo IL-4 challenge ( Figure 3C , cyan checkered boxes). Demonstrating the efficiency of this in vivo challenge protocol, adoptively transferred naive CD45.1 + macrophages ( Figure 3C , cyan) and CD45.2 + -resident macrophages (data not shown) efficiently upregulated the tested M2 surface markers upon IL-4c administration.
Overall, we showed that M1 macrophages also failed to convert into M2 cells upon an IL-4 challenge in vivo.
LPS + IFNg Treatment Blunts Mitochondrial Oxidative Respiration in Mouse Macrophages
Next, we further studied mouse BMMs to identify why M1 cells are unable to repolarize to M2. Because the minimum requirement for M1/M2 repolarization is an intact IL-4Ra-JAK-STAT6 pathway, we first assessed IL-4Ra expression and STAT6 phosphorylation. IL-4Ra levels were compared among naive, LPS + IFNg-induced M1, IL-4-induced M2, and M1/M2 macrophages ( Figure 4A ). M1 polarization actually enhanced IL-4Ra levels and also M1/M2 repolarized macrophages had increased levels compared to M2. Accordingly, M1/M2 repolarized macrophages showed effective STAT6 phosphorylation ( Figure 4B ). When assessing the viability of differentially stimulated macrophages, we observed a similar percentage of annexin V À propidium iodide (PI)
À living cells under all tested conditions ( Figure 4C ). However, M1 macrophages were less active than naive and, especially, M2 cells in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay ( Figure 4D ). Although this assay is often used to assess cell viability, it actually measures succinate dehydrogenase activity and, thus, mitochondrial function. Given identical annexin V PI staining (Figure 4 ), the changes observed in the MTT assay suggest metabolic differences in these macrophages. This prompted us to assess the metabolic characteristics of (re)polarized macrophages by extracellular flux analysis, particularly because recent evidence shows that macrophage polarization requires metabolic reprogramming (Galvá n-Peñ a and O'Neill, 2014). Changes in extracellular acidification rate (ECAR) in response to glucose, oligomycin (OM), and 2-deoxyglucose (2-DG) injection were used to calculate all glycolysis parameters. In parallel, OXPHOS characteristics were calculated from the changes in oxygen consumption rate (OCR) in response to OM, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), and rotenone (ROT) + antimycin A (AA) injection, as detailed in Figure S5 . We confirmed that M2 macrophages show enhanced OXPHOS and have the capacity to switch to glycolysis when mitochondrial ATP production is blocked with OM ( Figures 4E-4G ). In contrast, M1 macrophages exhibited increased glycolysis, complete suppression of OXPHOS, and reduced fatty acid oxidation (FAO) ( Figures 4E-4H ).
To gain insight into the mechanism of reduced mitochondrial oxygen consumption in M1 macrophages, we examined the effect of LPS + IFNg on different established metabolic readouts. Mitochondrial dysfunction in M1 cells was not caused by an LPS + IFNg-mediated suppression of mitochondrial (and glycolysis) genes nor by a reduction of mitochondrial mass, as demonstrated alike by MitoTracker Green staining and mtDNA/genomic DNA (gDNA) ratio ( Figures  S6A-S6D) . Also, the activity of citrate synthase, the pacemaker enzyme of the Krebs cycle, was not impaired in M1 ( Figure S6E ). Next, we measured the activity of the individual mitochondrial respiratory complexes I-IV (calculated as described in Table S1 ), using an established extracellular flux analysis protocol. LPS + IFNg treatment completely suppressed complex I and II activity and dampened complex II and IV activity partially ( Figure 4I , red bars). Importantly, the LPS + IFNg-mediated inhibition of the distinct electron transport chain complexes could not be restored by subsequent IL-4 restimulation (blue/white bars). Also, in intact cells, the LPS + IFNg-mediated suppression of mitochondrial respiration was not restored after subsequent IL-4 treatment, as demonstrated by the highly suppressed basal respiration, ATP synthase activity, maximal respiration, and spare respiratory capacity (calculated as described in Figure S5 ) observed in M1/M2 cells compared with naive controls and normal M2 macrophages ( Figure 4J ). Thus, M1 macrophages failed to repolarize to M2 cells phenotypically, functionally, and metabolically.
Mitochondrial Function Is Required for the Induction of an M2 Phenotype
Given that increased mitochondrial metabolism is both a characteristic of and requirement for the anti-inflammatory responses of M2 macrophages (Huang et al., 2014; Tan et al., 2015; Vats et al., 2006) , the suppression of OXPHOS by LPS + IFNg may impede M1/M2 repolarization. In support of this hypothesis, blocking mitochondrial ATP synthase activity with OM before IL-4 stimulation dampened OCRs ( Figure 5A ) and, thereby, completely abolished IL-4-induced Arg1, Cdh1, Chi3l3, and Retnla expression ( Figure 5B ). In the absence of mitochondrial ATP production, these macrophages relied on increased glycolysis to fulfill their energy demands ( Figure 5A ). Depending on the situation, both glucose and FAO can fuel mitochondrial function in M2 macrophages (Huang et al., 2014; Namgaladze and Br€ une, 2014; Tan et al., 2015; Vats et al., 2006 ). In the settings tested in the present study, 2-DG-mediated blocking of the glycolytic flux suppressed mitochondrial respiration ( Figure 5A ) and impaired M2-associated gene expression ( Figure 5B ). While FAO was suppressed by LPS + IFNg stimulation ( Figure 4H ), inhibiting FAO with etomoxir (ETO) did not prevent the induction of most M2-associated genes ( Figure 5B ). Confirming our gene expression data, macrophages pre-treated with 2-DG and, especially, OM exhibited a reduction of IL-4-induced CD71, CD206, and CD301 expression and arginase-1 activity ( Figures 5C and 5D ). Overall, these experiments showed that LPS + IFNg inhibited glucose-fueled mitochondrial respiration, thereby trapping macrophages in a metabolic state that prevented future IL-4-induced polarization.
NO Blunts Mitochondrial Respiration and Prevents Plasticity in M1 Macrophages
Next, we aimed to identify the mechanism underlying the LPS + IFNg-induced decline in mitochondrial function and prevention of future IL-4 responses. M1 cells display various features that could impede mitochondrial function and M1/M2 repolarization. First, if the macrophage metabolic machinery itself lacks plasticity, the induction of glycolysis by LPS + IFNg might impair subsequent IL-4-induced reprogramming toward OXHPOS. Moreover, as an antimicrobial mechanism, M1 cells produce reactive oxygen species (ROS) and iNOS-generated NO, which both inhibit mitochondrial function in other cell types (Everts et al., 2012; Raza et al., 2014) .
To assess these alternatives, we pre-treated macrophages with the glycolysis inhibitor 2-DG, the ROS scavenger N-acetylcysteine (NAC), or the iNOS inhibitor 1400W (Garvey et al., 1997) , followed by LPS + IFNg treatment (Figures 6A-6D ). Only iNOS inhibition markedly improved mitochondrial function in M1 macrophages, as demonstrated by a pronounced increase in basal respiration, mitochondrial ATP production, and maximal respiration in 1400W-pre-treated M1 cells ( Figure 6E ). While scavenging ROS with NAC did not improve mitochondrial function, 2-DG-treated M1 macrophages showed a slight increase in mitochondrial ATP production, possibly caused by the 2-DG-mediated inhibition of LPS + IFNg-induced NO production ( Figures 6D and 6E) .
Because iNOS inhibition dampened the LPS + IFNg-induced decline in mitochondrial function, we next tested whether this (legend continued on next page) strategy also could promote future IL-4 responses. For this purpose, we performed repolarization experiments in the presence of the iNOS inhibitor 1400W. iNOS inhibition during the first LPS + IFNg response markedly improved subsequent IL-4-induced metabolic reprogramming toward enhanced OXPHOS. Indeed, 1400W-pre-treated M1/M2 macrophages showed significantly higher basal respiration, ATP production, and maximal respiration compared with M1/M2 macrophages in which iNOS was not inhibited ( Figure 6F ). Accordingly, iNOS inhibition improved the activity of complexes I-IV of the electron transport chain in M1/M2 repolarized macrophages, as demonstrated by extracellular flux analysis on permeabilized macrophages and by the MTT assay ( Figures  6G and 6H ).
(C) BMMs were subjected to Annexin V plus PI staining to determine the percentage of AV À PI À viable cells.
(D) MTT assay was performed to measure mitochondrial succinate dehydrogenase activity.
(E-G) BMMs were seeded in Seahorse plates and stimulated for 24 hr. During extracellular flux analysis, cells were sequentially treated with (E) glucose, oligomycin (OM), and 2-deoxyglucose (2-DG), to determine glycolysis parameters from the ECAR levels, or with (F) OM, FCCP, and rotenone (ROT) plus antimycin A (AA), to assess OXPHOS parameters from the OCR levels. (G) All calculated metabolic parameters in M1 and M2 cells are shown relative to those in naive macrophages (N = 100%).
(H) Fatty acid oxidation (FAO) rates in naive, M1, and M2 macrophages were measured as described previously (Zhang et al., 2012) . To compare mitochondrial function in polarized and repolarized macrophages, BMMs were treated as indicated, followed by OCR measurement.
(I) Plasma membrane-permeabilized macrophages were provide with a cocktail of specific substrates and inhibitors to measure complex I-, II-, III-, and IV-mediated respiratory activity. Data were plotted as OCR in pmoles/min. (J) Using intact cells, the basal respiration, mitochondrial ATP production, maximal respiration, and spare respiratory capacity (SRC) were calculated and plotted as OCR in pmoles/min. Values represent mean ± SEM of three mice (*p < 0.05, **p < 0.01, and ***p < 0.001; ns, not significant). 
(legend continued on next page)
Importantly, the repair of mitochondrial function via iNOS inhibition was sufficient to significantly improve the repolarization capacity of M1 cells. As such, iNOS inhibition during the first M1 polarization improved the phenotypic plasticity of the cells, as demonstrated by the enhancement of IL-4-induced CD71, CD206, and CD301 expression in these macrophages ( Figure 6I ).
iNOS inhibition had no effect on M2 polarization, as pre-treatment with 1400W did not affect the IL-4-induced expression of M2-associated genes and surface markers ( Figure S7A ). Moreover, the enhanced plasticity of 1400W-pre-treated M1 macrophages was effectively due to the iNOS inhibitory effect of 1400W and not to overall inhibition of the first LPS + IFNg response. Indeed, 1400W did not block MHC-II, CD80, and CD86 expression ( Figure S7B ) or inflammatory cytokine secretion ( Figure S7C ). Thus, iNOS inhibition did not affect M1 and M2 polarization per se but improved M1/M2 repolarization.
Confirming these assays, Nos2 À/À macrophages showed improved M1/M2 phenotypic repolarization, associated with improved mitochondrial respiration. Evidently, Nos2 À/À macrophages did not produce NO, but exhibited normal M1 and M2 polarization ( Figures S8A-S8F ) Thus, NO impeded M1/M2 repolarization, but did not affect M1 and M2 polarization as such.
DISCUSSION
Distinct arginine metabolism was one of the first characteristics employed to define macrophage subsets (Munder et al., 1998) . M1 cells convert arginine into NO through iNOS activity and are crucial for host defense. However, sustained M1 activation can cause tissue damage and chronic inflammation. Therefore, a repair phase has to be initiated in which M2 cells predominate.
As the yin to the yang of M1, M2 macrophages are low in iNOS, show high arginase-1 activity, and promote tissue repair and resolution of inflammation (Van den Bossche et al., 2012) . As such, the course of infections and healing responses is often characterized by an apparent switch from M1 to M2 polarization (Das et al., 2015; Rigamonti et al., 2014; Van den Bossche et al., 2009 ). This transition can be caused by actual reprogramming of macrophages and/or replacement of M1 cells with recruited monocytes that differentiate into M2 under the influence of the newly established environment (Das et al., 2015) . Reshaping unbalanced macrophage polarization has been suggested as the holy grail of macrophage therapeutic targeting (Sica and Mantovani, 2012) . In support of this notion, reversal of M2-like tumorassociated macrophages into tumor-killing phagocytes has been used with great success in cancer therapy (Allavena et al., 1990; Colombo et al., 1992; Hagemann et al., 2008) . We now show that M2 macrophages are indeed highly plastic and easily adopt an M1-like inflammatory state. In sharp contrast, M1 cells completely fail to repolarize to M2 in vitro and in vivo, as demonstrated by strongly reduced M2-associated gene and surface protein expression. In support of our findings, previous studies have shown that in vitro IFNg priming dampens successive IL-4-induced expression of multiple M2-associated genes (Davis et al., 2013; Khallou-Laschet et al., 2010) . Furthermore, from a functional perspective, M1/M2 repolarized macrophages showed aberrant arginase activity and strongly impaired OXPHOS. Importantly, our thorough phenotypic, functional, and metabolic characterization supports our findings of irreversibility of M1/M2 polarization. If only the Nos2/Arg1 balance were employed as a readout for M1/M2, we would have incorrectly concluded that both M1 and M2 macrophages are fully reversible. Indeed, confirming previous data (Davis et al., 2013) , Arg1 was the only M2-associated gene that was still fully induced by IL-4 after prior LPS + IFNg treatment. Otherwise, M1 cells completely failed to repolarize to M2 macrophages.
We found that the metabolic characteristics of M1 cells prevented repolarization to an M2 state. Inhibiting OXPHOS through LPS + IFNg stimulation or via OM-mediated inhibition of ATP synthesis completely abolished M2 (re)polarization. Mitochondrial respiration was mainly fueled by glycolysis and not by FAO. These data contribute to the current opinion that the effect of ETO on M2 polarization is more complicated than previously envisioned (Huang et al., 2014; Namgaladze and Br€ une, 2014; Tan et al., 2015; Vats et al., 2006) . Confirming our observations, a very recent study applied a genetic strategy to disrupt FAO in macrophages and showed no role for FAO in M2 polarization (Nomura et al., 2016) .
Our data support the idea that inflammatory triggers induce glycolysis to rapidly provide energy for the clearance of intracellular pathogens by ROS and NO. We now show that, as a consequence of this respiratory burst, LPS + IFNg induces mitochondrial dysfunction that cannot be restored by subsequent IL-4 stimulation, thereby directly hampering M1/M2 repolarization. Inhibiting LPS + IFNg-induced NO production reduced mitochondrial dysfunction and improved phenotypic and metabolic M1/M2 repolarization. NO and NO-derived reactive nitrogen species can inactivate all iron-sulfur-containing complexes of the mitochondrial electron transport chain (Brown and Borutaite, 2007; Ché nais et al., 2002; Pearce and Pearce, 2013) . We found LPS + IFNg to decrease mainly complex I and complex II activity, with minor effects on complexes III and IV. This decline could not be reversed by IL-4, but it was at least partially prevented by iNOS inhibition.
To overcome mitochondrial dysfunction, glycolysis is necessary to maintain ATP production in NO-producing dendritic cells (Everts et al., 2012) . It has been suggested that increased glycolysis in inflammatory macrophages is mainly caused by reactive nitrogen species (Albina and Mastrofrancesco, 1993) . However, our data demonstrate that the enhanced glycolysis observed in M1 cells is not simply a consequence of NO production and associated mitochondrial dysfunction. In fact, LPS + IFNg treatment in the presence of the iNOS inhibitor induces even higher glycolysis, emphasizing that additional factors, such as HIF1a and PKM2, cooperate to induce glycolysis in M1 macrophages (Izquierdo et al., 2015; Palsson-McDermott et al., 2015) . The reason why iNOS inhibition induces glycolysis remains unstudied, but it might be attributable to glyceraldehyde-3-phosphate dehydrogenase activation. Indeed, NO induces ADP ribosylation of this glycolytic enzyme and thereby inhibits its activity (Dimmeler and Br€ une, 1993) .
Although iNOS inhibition clearly improved mitochondrial function in M1 cells, it only partially restored M1/M2 repolarization, highlighting the existence of additional mechanisms that prevent the conversion of inflammatory macrophages into anti-inflammatory cells. In support of this notion, human M1 macrophages did not secrete NO in vitro (data not shown), and, thus, additional unidentified mechanisms are clearly at play that prevent M1/M2 repolarization in mice and humans. Possibly itaconate contributes to the suppression of mitochondrial function in inflammatory macrophages. This antibacterial product is highly induced by inflammatory stimuli in both mouse and human macrophages, and it has been reported to impair the activity of complex II of the electron transport chain (Meiser et al., 2016; Michelucci et al., 2013; O'Neill and Pearce, 2016) . In patients, however, iNOS + macrophages are present in a variety of inflammatory diseases, and NO might therefore also impair M1/M2 repolarization in vivo in humans (Bingisser and Holt, 2001; Stö ger et al., 2012; Thomas and Mattila, 2014) . Our findings support the earlier notion that M1 macrophages are end-stage killer cells (Italiani and Boraschi, 2014) . Accordingly, neutrophils show an M1-like metabolism with high glycolysis and low OXPHOS. Their metabolism underlies the uniting characteristic of granulocytes, and these inflammatory phagocytes are short lived and terminally differentiated (Pearce and Pearce, 2013) . Indeed, M1 cells failed to adopt an M2 phenotype during an IL-4 challenge in vivo. These observations imply that the apparent switch from M1 to M2 macrophages during the course of infection or healing responses is probably not caused by actual M1/M2 repolarization of the macrophages that are present, but rather by the repopulation and M2 polarization of newly recruited blood monocytes in the healing-promoting environment, as suggested previously (Italiani and Boraschi, 2014) . The observation that inhibition or deletion of iNOS improves M1/M2 repolarization, without affecting M1 or M2 polarization as such, could help to explain previous in vivo findings in Nos2 À/À mice. Indeed, improved reprogramming of pro-atherogenic M1 cells to inflammation-resolving, pro-fibrotic M2 macrophages may underlie the decreased atherosclerosis (Kuhlencordt et al., 2001 ) and increased atherosclerotic collagen deposition (Niu et al., 2001 ) observed in Nos2 À/À mice.
Our thorough metabolic characterization of polarized and repolarized macrophages not only explains why M1 cells fail to repolarize to M2 but also simultaneously clarifies why M2 macrophages are highly plastic and readily repolarize to M1. Indeed, while exhibiting a modest basal glycolytic rate, M2 macrophages display high glycolytic reserves and immediately switch to high glycolysis after mitochondrial ATP production is blocked. How mitochondrial oxidative metabolism supports IL-4-induced polarization, as demonstrated here and by others (Tan et al., 2015; Vats et al., 2006) , remains elusive and deserves further investigation. In this context, we are currently investigating how metabolic changes affect metabolite availability for epigenetic enzymes and, through epigenetic remodeling, influence M1-and M2-associated gene expression .
Overall, the present study demonstrates that M1 activation of macrophages blunts OXPHOS, thereby preventing their repolarization to M2. Restoring mitochondrial function, for example, through iNOS inhibition, might be useful to improve the reprogramming of M1 into M2 macrophages as a method of controlling inflammatory diseases. /J) was a gift from Claude Libert (VIB, Ghent University). All experiments were approved by the Committee for Animal Welfare (University of Amsterdam).
Macrophage Cultures
Mouse bone marrow cells were isolated and cultured in RPMI-1640 with 2 mM L-glutamine, 10% fetal calf serum (FCS), penicillin (100 U/mL), streptomycin (100 mg/mL) (Gibco), and 15% L929-conditioned medium. Human peripheral mononuclear blood cells were isolated from healthy donors by density centrifugation using Lymphoprep (Axis-Shield). Next, monocytes were purified by magnetic-activated cell separation using human anti-CD14 beads and LS separation columns (Miltenyi). Cells were cultured in Iscove's modified Dulbecco's medium (IMDM, Life Technologies) with 10% FCS, penicillin (100 U/mL), streptomycin (100 mg/mL) (Gibco), and 25 ng/mL human macrophage-colony stimulating factor (M-CSF, Miltenyi) at 10 6 cells/mL. On day 6, cells were harvested, seeded at 10 6 cells/mL, and stimulated 24 hr with 10 U/mL IFNg (PeproTech) + 10 ng/ml LPS (Sigma-Aldrich) or 100 U/mL IL-4 (Peprotech) to elicit M1 or M2 cells, respectively. The 100 U/mL IL-10 (PeproTech) was used to elicit another type of M2-like macrophage. For repolarization, BMMs were primed with IL-4 or LPS + IFNg or they were left untreated. After 24 hr, cells were washed and treated with the opposing stimulus for another 24 hr. OM (2 mM), 2-DG (1 mM), ETO (50 mM), 1400W (100 mM), or NAC (5 mM) (all Sigma-Aldrich) was added 30 min before macrophage activation.
In Vivo Macrophage (Re)polarization To assess in vivo M1/M2 repolarization after IL-4 injection, BMMs from CD45.1 donor mice were stimulated ex vivo with LPS + IFNg or left untreated. After 24 hr, these CD45.1 + macrophages were harvested, washed in PBS, counted, analyzed for their M1 phenotype, and injected (2.5 3 10 6 cells per mouse) intraperitoneally into C57BL/6J(c) (CD45.2 + ) acceptor mice that next received IL-4 (or PBS as control). To optimize the effect of IL-4, it was administered as an IL-4/anti-IL-4 complex (IL-4c), consisting of 5 mg recombinant mouse IL-4 (PeproTech) and 25 mg 11B11 anti-IL-4 (BioConnect) in 100 ml PBS, as described previously (Jenkins et al., 2013) . Then 48 hr after the IL-4 challenge, peritoneal cells were collected and analyzed by flow cytometry.
Gene Expression Analysis RNA was isolated with High Pure RNA Isolation kits (Roche), cDNA was synthesized with iScript (Bio-Rad), and qPCR was performed using Sybr Green Fast mix (Applied Biosytems) on a ViiA7 (Applied Biosystems).
Housekeeping genes Rplp0 (Arbp) and Ppia were used for normalization. Primer sequences are available upon request.
Flow Cytometry
Cells were pre-incubated with Fc-block followed by the labeling antibodies listed in Table S2 . Cell viability was assessed by PI/Annexin V-Alexa-Fluor647 staining according to the manufacturer's protocol (Invitrogen). Data were acquired with a FACSCantoII (Becton Dickinson) and analyzed using FlowJo (Tree Star). Surface expression was calculated as DMFI = (Median fluorescence intensity) positive staining -(Median fluorescence intensity) isotype staining .
Macrophage Function IL-6, IL-12(p40), and TNF were quantified by ELISA in accordance with the supplier's protocols (Life Technologies). NO production was measured by NO 2 À quantification in a Griess reaction (Sigma-Aldrich). 2',7' -dichlorofluorescin diacetate (DCFDA) was used to measure ROS and oxidative stress was measured with CellROX (both Thermo Fisher Scientific). Arginase activity (1 U = amount of enzyme that catalyzes the formation of 1 mmol urea/min/10 6 cells) was assessed as described previously (Van den Bossche et al., 2012) .
Immunoblotting BMM lysates were separated on a NuPAGE Novex 4%-12% Bis-Tris gel (Thermo Fisher Scientific) and transferred onto nitrocellulose membrane (Bio-Rad). After blocking, membranes were incubated with primary antibodies (Table S2) , followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies and visualization using the SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific).
MTT Assay
Succinate dehydrogenase activity was assessed by yellow MTT reduction into purple formazan. Macrophages were incubated with 1 mg/mL MTT (Sigma-Aldrich) for 3 hr, lysed with 0.1 N HCl in isopropanol, and the released solubilized formazan was measured spectrophotometrically and compared to the levels in naive macrophages (N = 100%).
Metabolic Extracellular Flux Analysis
BMMs (25,000) were plated in XF-96-cell culture plates (Seahorse Bioscience) and treated as indicated. ECARs and OCRs were measured in an XF-96 Flux Analyzer (Seahorse Bioscience) as described previously . Changes in ECAR in response to glucose, OM, and 2-DG injection were used to calculate all glycolysis parameters, and OXPHOS characteristics were calculated from the OCR changes in response to OM, FCCP, and ROT + AA injection, as detailed in Figure S3 . FAO was measured as described previously (Zhang et al., 2012) . In brief, 200 mM palmitate-BSA complex was injected into XF-96-cell culture plates containing naive, M1, or M2 macrophages. Next, the fraction of OCR attributed to palmitate oxidation was determined by ETO (100 mM) injection and calculated as FAO = OCR before ETO -OCR after ETO . The activity of the individual mitochondrial respiratory complexes I-IV was measured using an established protocol (Salabei et al., 2014) . In brief, plasma membrane-permeabilized (PMP) macrophages were treated with a cocktail of specific substrates and inhibitors (all from Sigma-Aldrich; Table S1 ) to measure complex I-, II-, III-, and IV-mediated OCR. On completion of the distinct Seahorse experiments, DNA content was measured with CyQuant to normalize ECAR and OCR data.
Statistics
Data were evaluated with GraphPad Prism 4 using one-way ANOVA. Unless otherwise stated, values represent the mean ± SEM of three replicates of one representative experiment (*p < 0.05, **p < 0.01, and ***p < 0.001). 
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